Quality-of-life assessment in patients after laser prostatectomy

British Journal of Urology

Volumn 80, Issue 2, 1997, Pages 211-216

  Te Slaa, E ^a,b   Hendriks, J C M ^a   Kiemeney, L A L M ^a   Debruyne, F M J ^a   De La Rosette, J J M C H ^a  

^a Department of Urology ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Laser prostatectomy; Prostatic hypertrophy; Quality of life

Indexed keywords

ARTICLE; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RESIDUAL VOLUME; SCORING SYSTEM; SEXUAL FUNCTION; SYMPTOM; URINE FLOW RATE; UROFLOWMETRY;

EID: 0031403838     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00303.x     Document Type: Article

References (21)

1. Lytton B. Emery JM. Harvard B. The incidence of benign prostatic obstruction. J Ural 1968; 99: 639-45
2. Garraway WM, Collins GN. Lee RJ. High prevalence of benign prostatic hyperthrophy in the community. Lancet 1991; 338: 469-71
3. Drummond MF, McGuire AJ. Black NA, Petticrew M, Me Pherson CK. Economic burden of treated benign prostatic hyperplasia in the United Kingdom, fir J Urol 1993; 71: 290-6
4. Girman CJ, Epstein RS. Jacobsen SJ et al. Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urol 1994: 44: 825-31
5. The Department of Veterans Affairs cooperative study of transurethral resection for benign prostatic hyperplasia: a comparison of quality of life with patients reported symptoms and objective findings in men with benign prostatic hyperplasia. J Urol 1993: 150: 1696-700
6. te Slaa E, Mooibroek JJ, de Reijke ThM et al. Laser treatment of the prostate using the Urolase fiber: the Dutch experience. J Urol 1996; 156: 420-4
7. Kabalin JN. Laser prostatectomy performed with a right angled firing neodymium: YAG laser fiber at 40 watts power setting. J Urol 1993; 150: 95-9
8. Norris JP. Norris DM. Lee RD. Rubenstein MA. Visual laser ablation of the prostate: clinical experience in 108 patients. J Urol 1993: 150: 1612-4
9. de la Rosette JJMCH, te Slaa E, de Wildt ,VIJAM, Debruyne FMJ. Experience with the Ultraline and Urolase laser fibers: is there any difference? World J Urol 1995: 13: 98-103
10. Sagnier PP, MacFarlane G, Teillac P. Bolto H. Richard F. Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995: 153: 669-73
11. Bosch JLHR, Niemer AQHL, Kirkels WJ. Schröder FH. Signs and Symptoms of Benign Prostatic Hyperplasia in Men Screened for Prostatic Carcinoma. Benign Prostatic Hyperplasia: Recent Progress in Clinical Research and Practice. EORTC Genitourinary Group Monograph 12. Wiley-Liss, New York, 1994: 97-107
12. Fowler FJ Jr, Wennberg JE. Timothy RP, Barry MJ, Mulley AG Jr, Hanley D. Symptom status and quality of life following prostatectomy. JAMA 1988; 259: 3018-22
13. Bosch JLHR, Hop WCJ. Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a communitybased sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995: 75: 622-30
14. Barry MJ, Cockett ATK, Holtgrewe HL. McConnell JD, Sihelnik SA, Winfleld HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993; 150: 351-8
15. Fowler FJ Jr, Barry MJ. Quality of life assessment for evaluating benign prostatic hyperplasia treatments. An example of using a condition-specific index. Eur Urol 1993; 24 (Suppl 1): 24-7
16. Fowler FJ. Patient reports on symptoms and quality of life following prostate surgery. Eur Urol 1991; 20 (Suppl 2): 44-9
17. Lukacs B. McCarthy C, Grange JC and the Qol BPH Study Group in General Practice. Longterm quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7.093 patients treated with alpha-1-adrenergic blocker, alfuzosin. Eur Urol 1993; 24 (Suppl 1): 34-40
18. Emberton M. Neal DE, Black N et «J.The effect of prostatectomy on symptom severity and quality of life. Br J Urol 1996; 77: 233-47
19. Mebust WK. Donovan J, Bosch R et al. Symptoms evaluation, quality of life and sexuality. In Cockett ATK. Khoury S, Aso Y. Châtelain C, Denis L, Griffith K, Murphy G. The Third International Consultation on Benign Prostatic Hyperplasia (BPH). 1995; 3: 257-74
20. Guess HA. Chute CG, Garraway WM et al. Similar levels of urological symptoms have similar impact on Scottish and American men-although Scots report less symptoms. J Urol 1993; 150: 1701-5
21. Witjes WPJ. de la Rosette JJMCH. Donovan JL, Kay HE. Peters TJ, Abrams PH, and the ICS-BPH study group. The ICS-BPH Study: International differences in lower urinary tract symptoms and related bother in the eldery male patient. JUrol 1997; 157: 1295-1300